Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RJB 0402

Next Previous
X
Search
Drug Profile

RJB 0402

Alternative Names: RJB-0402

Latest Information Update: 29 Apr 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rejuvenate Bio
  • Developer Rejuvenate Bio; Rejuvenate Biomed
  • Class Cardiovascular therapies; Gene therapies
  • Mechanism of Action Fibroblast growth factor 21 expression stimulants; Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Cardiomyopathies; Familial partial lipodystrophy

Most Recent Events

  • 29 Apr 2024 Preclinical trials in Familial partial lipodystrophy in USA (Parenteral), before April 2024 (Rejuvenate Bio pipeline, April 2024)
  • 09 Oct 2023 Preclinical trials in Cardiomyopathies in USA (Parenteral)
  • 09 Oct 2023 Rejuvenate Bio plans a clinical trial for Desmoplakin-related arrhythmogenic cardiomyopathy (Parenteral)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top